Ofloxacin Ornidazole Suspension

Description

Ofloxacin & Ornidazole Oral Suspension (50 mg + 125 mg)

Healthy Inc is a specialized global supplier and exporter of advanced anti-infectives, pediatric medicine, and tropical health therapeutics. We provide ultra-high-purity, kinetically stabilized Ofloxacin & Ornidazole Suspension, manufactured in WHO–GMP certified, high-precision liquid manufacturing facilities. This “Advanced Quinolone & Nitroimidazole” combination is a massive-volume strategic export to retail pharmacies, pediatric hospitals, and government health ministries, serving as the globally preferred intervention for severe infectious diarrhea, amoebic dysentery, and mixed gastrointestinal infections where superior tolerability is required.

Product Overview

This formulation operates as a “Dual-Phase Intestinal Sterilizer.” It physically targets the DNA integrity of both complex bacteria and parasites to rapidly resolve severe gut infections with fewer side effects.

• Mechanism 1 (DNA Gyrase & Topoisomerase IV Inhibition – Ofloxacin): A potent fluoroquinolone that physically enters the bacterial cell to block the enzymes responsible for DNA replication. This leads to the rapid death of a wide range of pathogens, including Shigella, Salmonella, and E. coli.

• Mechanism 2 (Anaerobic DNA Fragmentation – Ornidazole): A superior nitroimidazole that physically targets Entamoeba histolytica and Giardia lamblia. It has a longer half-life than Metronidazole, meaning it physically stays active in the gut for longer periods.

• Mechanism 3 (Enhanced Tolerability): Ornidazole is chemically more stable and physically causes significantly less nausea, vomiting, and metallic taste compared to older anti-protozoals, ensuring higher completion of the treatment course in children.

Product Composition & Strength

We supply this product as a Sterile, Homogeneous, Micronized Suspension, optimized for stability and high pediatric compliance.

Technical & Logistics Specifications

• HS Code: 3004.20.19 (Medicaments containing other antibiotics / Antiprotozoals)

• CAS Numbers: 82419-36-1 (Ofloxacin) / 16773-42-5 (Ornidazole)

• Dosage Form: Oral Liquid (Suspension)

• Packaging: 30ml / 60ml Amber PET Bottles with child-resistant caps. Our specialized packaging ensures 36-month stability in Zone IVb tropical climates.

Manufacturing Authority & Compliance

• Micronized Homogenization: Both Ofloxacin and Ornidazole are physically insoluble. Our manufacturing process utilizes High-Shear Homogenization to ensure a perfectly smooth suspension, preventing “grittiness” and ensuring an exact dose in every spoon.

• Aseptic Filling: We utilize Automated Liquid Filling Lines with 100% microbial testing to ensure total safety for children with compromised gastrointestinal health.

• pH Precision: We utilize Precision Buffering to maintain the suspension at an optimal chemical state, preventing the degradation of the active molecules throughout the shelf life.

Primary Indications

• Pediatrics: Treatment of Severe Infectious Diarrhea and Amoebic Dysentery (bloody stools).

• Tropical Medicine: Management of Giardiasis and mixed intestinal infections with superior gastric comfort.

• Gastrology: Relief of severe abdominal cramps and frequent loose motions associated with infection.

• Public Health: Premium intervention for localized outbreaks of bacterial enteritis.

Dosage & Administration

• Children (2-5 years): Typically 5ml (one teaspoon) twice daily for 3 to 5 days.

• Children (6-12 years): Typically 10ml twice daily for 3 to 5 days.

• Administration: For maximum safety and to reduce potential gastric upset, it should physically be taken 1 hour before or 2 hours after food.

• Shake Well: The bottle must be physically shaken before each use to ensure both active components are evenly distributed.

Safety Warning: For Oral Use Only. Alcohol Warning: Strictly avoid alcohol during and for 48 hours after treatment (Disulfiram-like reaction). Tendon Note: While rare in children, Ofloxacin use should be physically monitored for any joint or tendon pain. Contraindication: Do not use in patients with a history of hypersensitivity to Quinolones or Nitroimidazoles.

Global Export & Contract Manufacturing

Healthy Inc is a premier Anti-Infective and Pediatric Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume anti-diarrheal suspensions. Whether you are a National Health Tender in the CIS or a B2B Pharma Marketplace partner in Africa or SE Asia, we ensure secure, WHO-GMP compliant delivery.